Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS)

被引:65
作者
Deters, M
Kirchner, G
Resch, K
Kaever, V
机构
[1] Hannover Med Sch, Inst Pharmakol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Gastroenterol, D-30625 Hannover, Germany
关键词
immunosuppressants; sirolimus; everolimus; tacrolimus; cyclosporine; LC-MS;
D O I
10.1515/CCLM.2002.045
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We developed a universal liquid chromatographymass spectrometry (LCMS) assay with automated online extraction to quantify simultaneously the immunosuppressants sirolimus, everolimus, tacrolimus, and cyclosporine. Whole blood (300 mul) plus 6 mul 32-desmethoxyrapamycin (1 ng/mul) as internal standard was treated with 600 mul methanol/0.2 M ZnSO4 (80/20 v/v). After vortexing (30 s) and centrifugation (20000 g, 5 min) 50 mul of the supernatant were loaded on an extraction column, were washed by 0.35 ml/min water for 3 min and, after activation of a columnswitching valve, were backflushed by 0.25 ml/min methanol/water (90/10 v/v) onto a C-18 analytical column. After 22 min the extraction column was washed for 2 min with methanol and for 3 min with water before starting the next run. Column temperatures were kept at 33 degreesC. Sodium adduct ions [M+Na](+) ions were detected in the selected ion mode. For sirolimus, everolimus and tacrolimus the assay was linear from 0.3 to 200 mug/l and for cyclosporine from 5 to 1000 mug/l (all r(2)>0.999). Recovery of all immunosuppressants and the internal standard was >90% and in general, interday and intraday precision was <10%. The simultaneous quantification of blood levels by LCMS seems to be the method of choice in transplanted patients receiving multiple immunosuppressants.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 42 条
[1]   An HPLC/MS/MS assay for tacrolimus in patient blood samples - Correlation with results of an ELISA assay [J].
Alak, AM ;
Moy, S ;
Cook, M ;
Lizak, P ;
Niggebiugge, A ;
Menard, S ;
Chilton, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 16 (01) :7-13
[2]   Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients [J].
Belitsky, P ;
Dunn, S ;
Johnston, A ;
Levy, G .
CLINICAL PHARMACOKINETICS, 2000, 39 (02) :117-125
[3]   The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation [J].
Böhler, T ;
Waiser, J ;
Budde, K ;
Lichter, S ;
Jauho, A ;
Fritsche, L ;
Korn, A ;
Neumayer, HH .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) :2195-2197
[4]  
CHRISTIANS U, 1992, CLIN CHEM, V38, P2025
[5]   Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants [J].
Christians, U ;
Jacobsen, W ;
Serkova, N ;
Benet, LZ ;
Vidal, C ;
Sewing, KF ;
Manns, MP ;
Kirchner, GI .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 748 (01) :41-53
[6]  
CHRISTIANS U, 1992, DRUG METAB DISPOS, V20, P186
[7]   CYCLOSPORINE METABOLISM IN TRANSPLANT PATIENTS [J].
CHRISTIANS, U ;
SEWING, KF .
PHARMACOLOGY & THERAPEUTICS, 1993, 57 (2-3) :291-345
[8]   COMPARISON OF CYCLOSPORINE MEASUREMENT IN WHOLE-BLOOD BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, MONOCLONAL FLUORESCENCE POLARIZATION IMMUNOASSAY, AND MONOCLONAL ENZYME MULTIPLIED IMMUNOASSAY [J].
DUSCI, LJ ;
HACKETT, LP ;
CHISWELL, GM ;
ILETT, KF .
THERAPEUTIC DRUG MONITORING, 1992, 14 (04) :327-332
[9]   CYCLOSPORINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN IMMUNOREGULATORY DISORDERS [J].
FAULDS, D ;
GOA, KL ;
BENFIELD, P .
DRUGS, 1993, 45 (06) :953-1040
[10]   SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY ASSAY FOR MEASUREMENT OF TACROLIMUS AND ITS METABOLITES AND CROSS-VALIDATION WITH MICROPARTICLE ENZYME-IMMUNOASSAY [J].
GONSCHIOR, AK ;
CHRISTIANS, U ;
WINKLER, M ;
SCHIEBEL, HM ;
LINCK, A ;
SEWING, KF .
THERAPEUTIC DRUG MONITORING, 1995, 17 (05) :504-510